USFDA Closes Zydus Inspection with NAI

  Published 9 months ago

USFDA inspection (Mar 10-14, 2025) closed as NAI; Zydus Lifesciences continues global healthcare operations.

  • Inspection concluded with no regulatory action needed.
  • Zydus discovers, develops, and markets diverse therapies worldwide.
  • Closure confirms compliance and operational standards met.

You might like these

AI Chip Export Controls: A 'Failure'

BlackRock's 2030 Growth: $35B Revenue, Private Markets Push

Why Rupee Lags Asian Currencies in Weak Dollar

Oswal Pumps IPO Oversubscribed 19x, Retail Demand Strong

P&G Hygiene Q1 PAT Jumps 137%

LTIMindtree Drives Media Digital Shift

MedPlus Q1 Profit Jumps 197% YoY

News that matters the most ⚡